WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role ...
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte ...
Demand forweight-loss drugs has grown at an astonishing rate in recent years, driving share prices of healthcare giants such ...
Roche argued that its obesity medications would prove to have advantages over its rivals’ — and that the demand for weight ...